Weiwei Ren

Dr. Weiwei Ren

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2020 in British Journal of Radiology
Verified
Journal Article
Closed access
CLChang Liu
Chang Liu
SDShi-Si Ding
Shi-Si Ding
KZKun Zhang
Kun Zhang
LLLinna Liu
Linna Liu
LGLe-Hang Guo
Le-Hang Guo
HXHuixiong Xu
Huixiong Xu
Objectives: The aim of this study was to develop an ultrasound consolidated score (UCS) in determining the activity of Crohn’s disease (CD) and evaluate it with reference to simple endoscopic score (SES). Methods: From June 2014 to June 2017, 66 patients with CD were retrospectively enrolled in this study. Each patient underwent endoscopy and transabdominal ultrasound (US) examination. The morphological symmetry, echogenicity of bowel wall, bowel wall layer structure, echogenicity of peri-bowel fat, bowel wall thickness (BWT), and Limberg type on power Doppler US were assessed with transabdominal US, and an UCS scoring system was developed based on these characteristics. Endoscopic results were used as the reference standard and SES was calculated to determine the CD activity. Receiver operating characteristic curve analysis was performed to assess the diagnostic performance for determining CD activity and the correlation between UCS and SES was assessed using Spearman correlation analysis. Results: 330 intestinal segments in 66 patients were included. The UCS of the segments in the remission phase ranged from 3.0 to 9.0 (mean, 3.6 ± 0.9) whereas in the active phase from 3.0 to 20.0 (mean, 10.6 ± 4.0) (p < 0.001). The cut-off value of UCS was 6. The associated area under ROC curve, sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 0.980, 88.3%, 95.5%, 93.8%, 91.3%, and 92.3%, respectively. The correlation coefficient between UCS and SES was 0.90, which was higher than the correlation coefficient of 0.83 between BWT and SES. Conclusions: The newly developed UCS with transabdominal US has a good performance and potentially provides an effective alternative for evaluating the activity of CD. Advances in knowledge: UCS is an effective method to evaluate the activity of CD because it provides comprehensive information of the disease. Therefore, it could be employed as an alternative for diagnosis of CD.

1 July 2024 in Ultrasonography
Verified
Journal Article
Open access
PDF file
QWQiao Wang
Qiao Wang
WRWeiwei Ren
Weiwei Ren
LWLifan Wang
Lifan Wang
XLXiaolong Li
Xiaolong Li
AZAnqi Zhu
Anqi Zhu
LSLiping Sun
Liping Sun
Purpose: This study examined the diagnostic value of high-frequency ultrasound (HFUS) features in differentiating between benign and malignant skin lesions.Methods: A total of 1,392 patients with 1,422 skin lesions who underwent HFUS examinations were included in an initial dataset (cohort 1) to identify features indicative of malignancy. Qualitative clinical and HFUS characteristics were recorded for all lesions. To determine which HFUS and clinical features were suggestive of malignancy, univariable and multivariable logistic regression analyses were employed. The diagnostic performance of HFUS features combined with clinical information was evaluated. This assessment was validated using internal data (cohort 2) and multicenter external data (cohort 3).Results: Features significantly associated with malignancy included age above 60 years; lesion location in the head, face, and neck or genital regions; changes in macroscopic appearance; crawling or irregular growth pattern; convex or irregular base; punctate hyperechogenicity; blood flow signals; and feeding arteries. The area under the receiver operating characteristic curve, sensitivity, and specificity of HFUS features combined with clinical information were 0.946, 92.5%, and 86.9% in cohort 1; 0.870, 93.1%, and 80.8% in cohort 2 (610 lesions); and 0.864, 86.2%, and 86.6% in cohort 3 (170 lesions), respectively. However, HFUS is not suitable for evaluating lesions less than 0.1 mm in thickness or lesions exhibiting surface hyperkeratosis.Conclusion: In a clinical setting, the integration of HFUS with clinical information exhibited good diagnostic performance in differentiating malignant and benign skin lesions. However, its utility was limited in evaluating extremely thin lesions and those exhibiting hyperkeratosis.

25 October 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
DLDan-Hua Li
Dan-Hua Li
FYFeiyue Yang
Feiyue Yang
YZYang Zhao
Yang Zhao
QWQiao Wang
Qiao Wang
WRWeiwei Ren
Weiwei Ren
CQChuan Qin
Chuan Qin
Background: Dermatofibroma has various pathological classifications, some of which pose a risk of recurrence and metastasis. Distinguishing these high-risk dermatofibromas based on appearance alone can be challenging. Therefore, high-frequency ultrasound may provide additional internal information on these lesions, helping to identify high-risk and low-risk dermatofibroma early. Methods: In this retrospective study, 50 lesions were analyzed to explore the correlation between clinical and high-frequency ultrasound features and dermatofibroma risk level. Based on their pathological features, the lesions were divided into high-risk (n = 17) and low-risk (n = 33) groups. Subsequently, an identification model based on significant high-frequency ultrasound features was developed. Results: Significant differences were observed in the thickness, shape, internal echogenicity, stratum basal, and Doppler vascular patterns between the high-risk and low-risk groups. The median lesion thickness for the high-risk dermatofibroma group was 4.1 mm (IQR: 3.2–6.1 mm), while it was 3.1 mm (IQR: 1.3–4.2 mm) for the low-risk dermatofibroma group. In the high-risk dermatofibroma group, irregular morphology was predominant (70.6%, 12/17), the most common being dermis-to-subcutaneous soft tissue penetration (64.7%, 11/17), and heterogenous internal echogenicity was observed in the majority of cases (76.5%, 13/17). On the other hand, regular morphology was more prevalent in the low-risk dermatofibroma group (78.8%, 26/33), primarily limited to the dermis layer (78.8%, 26/33), with homogeneous internal echogenicity also being prevalent in the majority of cases (81.8%, 27/33). Regarding the Doppler vascularity pattern, 69.7% (23/33) of low-risk dermatofibromas had no blood flow, while 64.7% (11/17) of high-risk dermatofibromas had blood flow. Conclusion: High-frequency ultrasound is crucial in distinguishing high-risk and low-risk dermatofibromas, making it invaluable for clinical management.

5 January 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
YZYang Zhao
Yang Zhao
FYFeiyue Yang
Feiyue Yang
DLDan-Hua Li
Dan-Hua Li
QWQiao Wang
Qiao Wang
LGLe-Hang Guo
Le-Hang Guo
CQChuan Qin
Chuan Qin
Introduction: The Breslow thickness of cutaneous melanoma (CM) is related to the surgical approach and is usually measured using a preoperative biopsy. However, tumor thickness is often underestimated by partial biopsies. Objectives: To identify whether high-frequency ultrasound (HFUS) can improve the accuracy of preoperative detection of Breslow thickness. Methods: Partial biopsies and HFUS measurements of Breslow thickness were analyzed in 17 patients with CM. Postoperative histopathologic examination is considered the gold standard. In different thicknesses, HFUS and partial biopsy were compared with postoperative pathology and their effects on tumor T staging and surgical margins. Results: The mean (±SD) Breslow thicknesses measured using HFUS, partial biopsy, and postoperative histopathology were 3.5 ± 2.2 mm, 1.8 ± 1.1 mm, and 3.2 ± 2.1 mm, respectively. The correlation coefficients were 0.76 (partial biopsy and postoperative histopathology) and 0.96 (HFUS and postoperative histopathology), respectively (all p < 0.01). Partial biopsy underestimated the Breslow thickness, and with a gradual increase in CM thickness, the underestimation became increasingly obvious. Partial biopsy led to an underestimation of T staging of the tumor in 8 (8/17 [47.1%]) patients, 4 (4/8 [50.0%]) of whom may have had insufficient surgical peripheral margins. Conversely, HFUS exhibited a significant downward trend of underestimation (0/17 [0%], p = 0.003). However, only 2 (2/17 [11.8%]) patients had slight overestimation for T staging (p = 0.485), and none of the overestimations changed the surgical margins. Conclusions: HFUS can provide an accurate preoperative assessment of Breslow thickness, and correlates better with postoperative histopathology.

26 June 2024 in Heliyon
Verified
Journal Article
Open access
FYFei-Yue Yang
Fei-Yue Yang
XWXiu Wang
Xiu Wang
SLShao-Yi Lu
Shao-Yi Lu
YZYujing Zhao
Yujing Zhao
WRWeiwei Ren
Weiwei Ren
Primary leiomyosarcoma of the breast was a rare malignant tumor. Due to the extremely low morbidity and insufficient understanding of its imageological characteristics, there was a risk of misdiagnosis. In this case report, we presented the features of conventional US, elastography, automated breast volume scanner (ABVS), computed tomography (CT), and pathological findings of a case of primary leiomyosarcoma of the breast. A 74-year-old woman detected a mass of the left breast by palpation. Both ultrasound and CT revealed a solid mass in the outer quadrant of the left breast. After admission, she underwent a modified radical unilateral mastectomy under general anesthesia (resection of the lesion with left breast reserved). Furthermore, the intraoperative frozen section revealed malignant spindle cells, and the postoperative histopathology revealed primary leiomyosarcoma of the breast. After discharge, the patient was generally in good condition after the procedure and was asked to seek medical treatment in the oncology department. Findings on various imaging examinations and clinical data were carefully evaluated. Additionally, we also reviewed the associated kinds of literature. We reported the features of conventional US, elastography, ABVS, CT, and pathological findings of a rare case of primary leiomyosarcoma of the breast. Overall, our findings indicated that the above-mentioned features generally predict malignancy. However, compared to other malignant breast lesions, the features of this case were not specific enough.

25 June 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
HYHaojie Yang
Haojie Yang
NNNa Ni
Na Ni
WRWeiwei Ren
Weiwei Ren
QWQiao Wang
Qiao Wang
MLMengyu Lu
Mengyu Lu
LSLiping Sun
Liping Sun
Objectives: Unlike other body parts, unclarified lesions at the end of extremities have unique challenges due to their small size and interference. Traditional imaging methods struggle with low resolution. HFUS enhances resolution, offering a potential diagnostic value. Methods: From January 2019 to October 2023, the clinical and HFUS data of patients with unclarified lesions at the end of extremities were retrospectively analyzed. Independently, the diagnosis was made using two diagnostic modes (Mode A: only clinical information; Mode B: clinical and HFUS information). The diagnostic performance of the two modes was evaluated across different classification methods. Results: For all lesions, the correct rate of Mode B was higher than that of Mode A (52.8% vs. 18.4%, p < 0.001), and the indeterminate rate decreased by 43.0%. For benign lesions (51.0% vs. 18.2%), subungual lesions (40.8% vs. 21.1%), non-subungual lesions (55.6% vs. 17.8%), and common cases (60.9% vs. 20.3%), the diagnostic correct rate of Mode B was also higher than that of Mode A (all p < 0.05). However, there was no significant difference in rare lesions (9.8% vs. 4.9%) and malignant lesions (62.9% vs. 19.4%) between the two modes (both p > 0.05). Moreover, the indeterminate rate for all categories of lesions significantly diminished. Otherwise, Mode B demonstrated strong performance for malignant lesions (85.7% vs. 42.9%, p < 0.001). Conclusions: Adding HFUS can significantly improve the accuracy of diagnosing unclarified lesions at the end of extremities and reduce uncertainty, especially for benign and common lesions. HFUS has also demonstrated better performance in screening for malignant lesions.